Cabaletta Bio, Inc. (CABA)
NASDAQ:CABA
Total Valuation
Cabaletta Bio has a market cap or net worth of $329.52M. The enterprise value is $229.06M.
Market Cap$329.52M
Enterprise Value$229.06M
Share Statistics
Cabaletta Bio has 111,322,670 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding111,322,670
Owned by Insiders1.76%
Owned by Institutions46.42%
Financial Efficiency
Cabaletta Bio’s return on equity (ROE) is -1.50 and return on invested capital (ROIC) is -123.78%.
Return on Equity (ROE)-1.50
Return on Assets (ROA)-1.02
Return on Invested Capital (ROIC)-123.78%
Return on Capital Employed (ROCE)-1.50
Revenue Per Employee0.00
Profits Per Employee-1.04M
Employee Count161
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cabaletta Bio is ―. Cabaletta Bio’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.00
PB Ratio2.00
Price to Fair Value2.00
Price to FCF-1.69
Price to Operating Cash Flow-2.31
PEG Ratio0.04
Income Statement
In the last 12 months, Cabaletta Bio had revenue of 0.00 and earned -167.86M in profits. Earnings per share was -1.64.
Revenue0.00
Gross Profit-1.65M
Operating Income-172.24M
Pretax Income-167.86M
Net Income-167.86M
EBITDA-170.59M
Earnings Per Share (EPS)-1.64
Cash Flow
In the last 12 months, operating cash flow was -131.08M and capital expenditures -1.23M, giving a free cash flow of -132.31M billion.
Operating Cash Flow-131.08M
Free Cash Flow-132.31M
Free Cash Flow per Share-1.19
Dividends & Yields
Cabaletta Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta4.04
52-Week Price Change159.65%
50-Day Moving Average2.94
200-Day Moving Average2.29
Relative Strength Index (RSI)51.88
Average Volume (3m)2.35M
Important Dates
Cabaletta Bio upcoming earnings date is May 20, 2026, Before Open (Confirmed).
Last Earnings DateMar 23, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
Cabaletta Bio as a current ratio of 2.77, with Debt / Equity ratio of 24.18%
Current Ratio2.77
Quick Ratio2.77
Debt to Market Cap0.12
Net Debt to EBITDA0.33
Interest Coverage Ratio-85.95
Taxes
In the past 12 months, Cabaletta Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Cabaletta Bio EV to EBITDA ratio is -0.99, with an EV/FCF ratio of -1.27.
EV to Sales0.00
EV to EBITDA-0.99
EV to Free Cash Flow-1.27
EV to Operating Cash Flow-1.28
Balance Sheet
Cabaletta Bio has $133.60M in cash and marketable securities with $27.10M in debt, giving a net cash position of $106.50M billion.
Cash & Marketable Securities$133.60M
Total Debt$27.10M
Net Cash$106.50M
Net Cash Per Share$0.96
Tangible Book Value Per Share$1.10
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Cabaletta Bio is $15.17, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.17
Price Target Upside412.50% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast―
EPS Growth Forecast-17.21%